2024 Q1 Form 10-K Financial Statement

#000141210024000014 Filed on March 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $28.90M $22.64M $83.37M
YoY Change 48.28% 133.18% 43.42%
Cost Of Revenue $11.63M $61.23M
YoY Change 18.44% 5.58%
Gross Profit $17.28M $22.14M
YoY Change 78.54% 15604.96%
Gross Profit Margin 59.78% 26.56%
Selling, General & Admin $8.060M $7.062M $30.80M
YoY Change -20.26% -41.03% -37.73%
% of Gross Profit 46.65% 139.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.593M $19.46M
YoY Change 32.07% 5.14%
% of Gross Profit 32.37% 87.89%
Operating Expenses $2.760M $36.73M $111.5M
YoY Change -12.27% -23.4% 858.28%
Operating Profit $14.52M -$89.34M
YoY Change 122.27% 677.36%
Interest Expense $6.206M -$7.146M -$18.11M
YoY Change -206.8% -54.48% 63.46%
% of Operating Profit 42.74%
Other Income/Expense, Net
YoY Change
Pretax Income $864.0K -$21.24M -$46.22M
YoY Change -107.64% -60.63% -23.73%
Income Tax $11.00K $449.0K $196.0K
% Of Pretax Income 1.27%
Net Earnings $1.459M -$20.78M -$38.57M
YoY Change -112.88% -157.66% -35.76%
Net Earnings / Revenue 5.05% -91.79% -46.26%
Basic Earnings Per Share $0.01 -$0.38
Diluted Earnings Per Share $0.01 -$0.21 -$0.38
COMMON SHARES
Basic Shares Outstanding 100.5M shares 100.9M shares 101.4M shares
Diluted Shares Outstanding 100.5M shares 101.4M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $20.72M $35.41M $35.41M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $167.0K $228.0K $228.0K
YoY Change -56.28% -24.0% -24.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $82.16M $727.6M $727.6M
YoY Change 14.27% 807.71% -3.63%
Other Assets $9.449M $7.266M $7.266M
YoY Change -44.96% -53.54% -53.54%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.469B $1.519B $1.519B
YoY Change -16.35% -17.76% -17.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $30.77M $28.24M $28.24M
YoY Change -39.64% -53.33% -53.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $30.77M $28.24M $28.24M
YoY Change -39.64% -53.33% -53.33%
LONG-TERM LIABILITIES
Long-Term Debt $254.6M $254.6M $254.6M
YoY Change 0.01% -0.38% -0.38%
Other Long-Term Liabilities $78.22M $73.24M $73.24M
YoY Change 58.73% 53.52% 53.52%
Total Long-Term Liabilities $332.9M $327.8M $327.8M
YoY Change 9.53% 8.1% 8.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.77M $28.24M $28.24M
Total Long-Term Liabilities $332.9M $327.8M $327.8M
Total Liabilities $1.220B $1.270B $1.270B
YoY Change -17.89% -18.72% -18.72%
SHAREHOLDERS EQUITY
Retained Earnings -$485.5M -$486.9M
YoY Change 5.61% 9.95%
Common Stock $1.501M $1.497M
YoY Change 0.33% 0.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $249.4M $249.2M $249.2M
YoY Change
Total Liabilities & Shareholders Equity $1.469B $1.519B $1.519B
YoY Change -16.35% -17.76% -17.76%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $1.459M -$20.78M -$38.57M
YoY Change -112.88% -157.66% -35.76%
Depreciation, Depletion And Amortization $5.593M $19.46M
YoY Change 32.07% 5.14%
Cash From Operating Activities $8.049M $6.219M -$59.78M
YoY Change -139.56% -106.47% -69.49%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $122.0K $7.375M $58.51M
YoY Change 1425.0% -89.37% 66390.91%
Cash From Investing Activities -$19.74M $7.375M $58.51M
YoY Change -229.27% -89.37% -69.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$2.920M
YoY Change -389.4%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$673.0K -1.044M -3.015M
YoY Change 133.68% -72.55%
NET CHANGE
Cash From Operating Activities $8.049M 6.219M -59.78M
Cash From Investing Activities -$19.74M 7.375M 58.51M
Cash From Financing Activities -$673.0K -1.044M -3.015M
Net Change In Cash -$12.51M 12.55M -4.281M
YoY Change 137.66% -147.03% -78.0%
FREE CASH FLOW
Cash From Operating Activities $8.049M $6.219M -$59.78M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Registrant Name
EntityRegistrantName
MAIDEN HOLDINGS, LTD.
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Pembroke
CY2023 dei Entity Address Country
EntityAddressCountry
BM
CY2023 dei Local Phone Number
LocalPhoneNumber
298-4900
CY2023 dei Trading Symbol
TradingSymbol
MHLD
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
7848000 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
-5140000 usd
CY2022 us-gaap Revenues
Revenues
58132000 usd
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001412100
CY2023Q4 us-gaap Investment Type Extensible Enumeration
InvestmentTypeExtensibleEnumeration
http://www.maiden.bm/20231231#NotesReceivableRelatedPartyMember
CY2022Q4 us-gaap Investment Type Extensible Enumeration
InvestmentTypeExtensibleEnumeration
http://www.maiden.bm/20231231#NotesReceivableRelatedPartyMember
CY2022Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
CY2023Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssets
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssets
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
D0
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0570192
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
94 Pitts Bay Road, 1st Floor
CY2023 dei City Area Code
CityAreaCode
441
CY2023 dei Security12b Title
Security12bTitle
Common Shares, par value $0.01 per share
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
175100000 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
100472120 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
42
CY2023 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2023 dei Auditor Location
AuditorLocation
New York, NY
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
258536000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
330439000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
250601000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
314527000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
43439000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
40509000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
45299000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
43621000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
80929000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
80159000 usd
CY2023Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
1023000 usd
CY2023Q4 us-gaap Other Investments
OtherInvestments
182811000 usd
CY2022Q4 us-gaap Other Investments
OtherInvestments
148753000 usd
CY2023Q4 us-gaap Investments
Investments
559640000 usd
CY2022Q4 us-gaap Investments
Investments
587060000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35412000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30986000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7266000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
15638000 usd
CY2023Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
4532000 usd
CY2022Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
4122000 usd
CY2023Q4 us-gaap Premiums Receivable Allowance For Doubtful Accounts
PremiumsReceivableAllowanceForDoubtfulAccounts
187000 usd
CY2023Q4 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
12450000 usd
CY2022Q4 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
10707000 usd
CY2023 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Writeoff
DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff
3240000 usd
CY2023Q4 us-gaap Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
564331000 usd
CY2022Q4 us-gaap Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
556116000 usd
CY2023Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
167975000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
167975000 usd
CY2023Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
17566000 usd
CY2022Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
24976000 usd
CY2023Q4 us-gaap Funds Held Under Reinsurance Agreements Asset
FundsHeldUnderReinsuranceAgreementsAsset
143985000 usd
CY2022Q4 us-gaap Funds Held Under Reinsurance Agreements Asset
FundsHeldUnderReinsuranceAgreementsAsset
441412000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
5777000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
7874000 usd
CY2023Q4 us-gaap Assets
Assets
1518934000 usd
CY2022Q4 us-gaap Assets
Assets
1846866000 usd
CY2023Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
867433000 usd
CY2022Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
1131408000 usd
CY2023Q4 us-gaap Unearned Premiums
UnearnedPremiums
46260000 usd
CY2022Q4 us-gaap Unearned Premiums
UnearnedPremiums
67081000 usd
CY2023Q4 mhld Deferred Gain On Reinsurance
DeferredGainOnReinsurance
73240000 usd
CY2022Q4 mhld Deferred Gain On Reinsurance
DeferredGainOnReinsurance
47708000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
28244000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
60518000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
262361000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
262500000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7764000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6928000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
254597000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
255572000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1269774000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1562287000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
149732355 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
149224080 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100472120 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101532151 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1497000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1492000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
886072000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
884259000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-31469000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-41234000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-486945000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-442863000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
49260235 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
47691929 shares
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
119995000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
117075000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
249160000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
284579000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1518934000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1846866000 usd
CY2023 us-gaap Premiums Written Gross
PremiumsWrittenGross
23466000 usd
CY2022 us-gaap Premiums Written Gross
PremiumsWrittenGross
5479000 usd
CY2023 us-gaap Premiums Written Net
PremiumsWrittenNet
23168000 usd
CY2022 us-gaap Premiums Written Net
PremiumsWrittenNet
5082000 usd
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
37378000 usd
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
30070000 usd
CY2023 us-gaap Revenues
Revenues
89234000 usd
CY2023 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
61228000 usd
CY2022 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
57991000 usd
CY2023 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
19462000 usd
CY2022 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
18511000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30796000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30947000 usd
CY2023 mhld Interest And Amortization Expenses Net
InterestAndAmortizationExpensesNet
18226000 usd
CY2022 mhld Interest And Amortization Expenses Net
InterestAndAmortizationExpensesNet
19331000 usd
CY2023 mhld Foreign Currency Transactionand Other Gain Lossbefore Tax
ForeignCurrencyTransactionandOtherGainLossbeforeTax
-5741000 usd
CY2022 mhld Foreign Currency Transactionand Other Gain Lossbefore Tax
ForeignCurrencyTransactionandOtherGainLossbeforeTax
8255000 usd
CY2023 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
135453000 usd
CY2022 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
118525000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-46219000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-60393000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
196000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-557000 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7846000 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-205000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-38569000 usd
CY2023 mhld Gain Loss From Repurchase And Exchange Of Preference Shares
GainLossFromRepurchaseAndExchangeOfPreferenceShares
0 usd
CY2022 mhld Gain Loss From Repurchase And Exchange Of Preference Shares
GainLossFromRepurchaseAndExchangeOfPreferenceShares
115473000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38569000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-38569000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
55432000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
55432000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101382606 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87112711 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101382606 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87113974 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-38569000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-60041000 usd
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
7977000 usd
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-10906000 usd
CY2023 us-gaap Oci Equity Method Investment Before Tax
OciEquityMethodInvestmentBeforeTax
0 usd
CY2022 us-gaap Oci Equity Method Investment Before Tax
OciEquityMethodInvestmentBeforeTax
4414000 usd
CY2023 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 usd
CY2022 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
6807000 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
1881000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-16044000 usd
CY2023 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
9858000 usd
CY2022 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-29343000 usd
CY2023 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
93000 usd
CY2022 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-324000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9765000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-29019000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28804000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-89060000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
249160000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
284579000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-38569000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-60041000 usd
CY2023 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-1020000 usd
CY2022 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-112000 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7846000 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-205000 usd
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
7848000 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
-5140000 usd
CY2023 mhld Allowance For Credit Loss Period Increase Decrease
AllowanceForCreditLossPeriodIncreaseDecrease
-1049000 usd
CY2022 mhld Allowance For Credit Loss Period Increase Decrease
AllowanceForCreditLossPeriodIncreaseDecrease
0 usd
CY2023 mhld Foreign Currency Transactionand Other Gain Lossbefore Tax
ForeignCurrencyTransactionandOtherGainLossbeforeTax
-5741000 usd
CY2022 mhld Foreign Currency Transactionand Other Gain Lossbefore Tax
ForeignCurrencyTransactionandOtherGainLossbeforeTax
8255000 usd
CY2023 us-gaap Increase Decrease In Premiums Receivable
IncreaseDecreaseInPremiumsReceivable
1494000 usd
CY2022 us-gaap Increase Decrease In Premiums Receivable
IncreaseDecreaseInPremiumsReceivable
-8530000 usd
CY2023 us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-14088000 usd
CY2022 us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-10822000 usd
CY2023 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
387000 usd
CY2022 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-1245000 usd
CY2023 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-7404000 usd
CY2022 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-11601000 usd
CY2023 us-gaap Increase Decrease In Funds Held Under Reinsurance Agreements
IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements
-27444000 usd
CY2022 us-gaap Increase Decrease In Funds Held Under Reinsurance Agreements
IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements
-3926000 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1866000 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1915000 usd
CY2023 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-4189000 usd
CY2022 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-154974000 usd
CY2023 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-20785000 usd
CY2022 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-32655000 usd
CY2023 mhld Deferred Gain On Retroactive Reinsurance
DeferredGainOnRetroactiveReinsurance
0 usd
CY2022 mhld Deferred Gain On Retroactive Reinsurance
DeferredGainOnRetroactiveReinsurance
-2335000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-33134000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
18220000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59778000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-195928000 usd
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
183575000 usd
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
79027000 usd
CY2023 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
45324000 usd
CY2022 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
39928000 usd
CY2023 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
12616000 usd
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
55629000 usd
CY2023 us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
6324000 usd
CY2022 us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
17281000 usd
CY2023 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
98993000 usd
CY2022 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
213944000 usd
CY2023 mhld Proceeds From Maturities Prepayments And Calls Of Debt Securities Investing Activities
ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtSecuritiesInvestingActivities
161551000 usd
CY2022 mhld Proceeds From Maturities Prepayments And Calls Of Debt Securities Investing Activities
ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtSecuritiesInvestingActivities
98462000 usd
CY2023 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
17570000 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
4403000 usd
CY2023 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
20200000 usd
CY2022 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
61209000 usd
CY2023 mhld Proceeds From Equity Securities Distribution
ProceedsFromEquitySecuritiesDistribution
8138000 usd
CY2022 mhld Proceeds From Equity Securities Distribution
ProceedsFromEquitySecuritiesDistribution
0 usd
CY2023 us-gaap Proceeds From Previous Acquisition
ProceedsFromPreviousAcquisition
0 usd
CY2022 us-gaap Proceeds From Previous Acquisition
ProceedsFromPreviousAcquisition
2725000 usd
CY2023 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
101000 usd
CY2022 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
88000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
58512000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
188790000 usd
CY2023 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
0 usd
CY2022 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
9984000 usd
CY2023 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
95000 usd
CY2022 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2920000 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1009000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3015000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10983000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
335000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1342000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3946000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19463000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46624000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66087000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42678000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46624000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35412000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30986000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7266000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
15638000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42678000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46624000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
19106000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
19106000 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
147000 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
1149000 usd
CY2023 us-gaap Nature Of Operations
NatureOfOperations
Organization<div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maiden Holdings, Ltd. (sometimes referred to as "Maiden Holdings" or "Parent Company") is a Bermuda-based holding company. Together with its subsidiaries (collectively referred to as the "Company", "we" or "Maiden"), Maiden creates shareholder value by actively managing and allocating our assets and capital, including through ownership and management of businesses and assets primarily in the insurance and related financial services industries where we can leverage our deep knowledge of those markets. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In November 2020, the Company formed our indirect wholly owned subsidiary Genesis Legacy Solutions ("GLS") which specialized in providing a full range of legacy services to small insurance entities, particularly those in run-off or with blocks of reserves that are no longer core to those companies' operations, working with clients to develop and implement finality solutions including acquiring entire companies. The Company believed the formation of GLS was highly complementary to its overall longer-term strategy. However, a combination of factors, including market conditions in the sector GLS focuses on, resulted in an inability for GLS to gain sufficient scale to achieve its objectives or earn a profit, and GLS results did not reach the objectives the Company expected it to over time. Having completed the capital commitment made to GLS in 2020, the Company has determined to not commit any additional capital to new opportunities and to run-off the existing accounts underwritten by GLS. The Company does not presently underwrite prospective reinsurance risks. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term income protection business is written on a primary basis by our wholly owned subsidiaries Maiden Life Försäkrings AB ("Maiden LF") and Maiden General Försäkrings AB ("Maiden GF") in the Scandinavian and Northern European markets. Our wholly owned subsidiary, Maiden Global Holdings Ltd. (“Maiden Global”) is a licensed intermediary in the United Kingdom. Maiden Global had previously operated internationally by providing branded auto and credit life insurance products through insurer partners, particularly those in Europe and other global markets ("IIS business"). These products also produced reinsurance programs which were underwritten by our wholly owned subsidiary Maiden Reinsurance Ltd. (“Maiden Reinsurance”). In 2023 and through the date of this report, the Company has been evaluating the strategic value of Maiden LF and Maiden GF in relation to their ongoing growth and profitability prospects, regulatory capital requirements and ability to create shareholder value in excess of our target return on capital levels. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company also has various historic reinsurance programs underwritten by Maiden Reinsurance which are in run-off, including the liabilities associated with AmTrust Financial Services, Inc. ("AmTrust") reinsurance agreements which were terminated in 2019 as discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">"Note 10 — Related Party Transactions"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. In addition, the Company has a retroactive reinsurance agreement and a commutation agreement that further reduces its exposure and limits the potential volatility related to AmTrust liabilities, which are discussed in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Note 8 — Reinsurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">" of the Notes to Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Exchange of Preference Shares</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On December 27, 2022 ("Exchange Date"), the Company exchanged all of its outstanding 8.250% Non-Cumulative Preference Shares, Series A (the “Series A Preference Shares”), 7.125% Non-Cumulative Preference Shares, Series C (the “Series C Preference Shares”) and 6.700% Non-Cumulative Preference Shares, Series D (the “Series D Preference Shares” and, together with the Series A Preference Shares and the Series C Preference Shares, the “Preference Shares”) for its common shares, $0.01 par value per share ("Exchange"). The Company offered three common shares as consideration for each share of the Series A, C and D Preference Shares tendered. A total of 1,500,050 shares of Series A Preference Shares, 1,744,028 shares of Series C Preference Shares, and 1,542,806 shares of Series D Preference Shares were accepted, resulting in 14,360,652 common shares issued to non-affiliates at a fair value of $28,434. The Exchange was accounted for as an extinguishment resulting in derecognition of the $119,672 carrying amount of Series A, C and D Preference Shares tendered, elimination of $3,998 of original issuance costs, and recognition of $25,915 as the excess of the fair value of the common shares issued over par value, net of $2,375 issuance costs, as additional paid in capital. The Company recognized a gain of $87,240 as the excess of the carrying amount of the Preference Shares extinguished over the fair value of the common shares issued as an increase to retained earnings.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The number of the Company's Series A, C and D Preference Shares held by Maiden Reinsurance pursuant to the tender offer in 2020 to repurchase Preference Shares and the Board authorizations to repurchase Preference Shares approved on March 3, 2021 and May 6, 2021 ("2021 Preference Share Repurchase Program") was 13,813,116 at the Exchange Date. Therefore, 41,439,348 common shares were issued to Maiden Reinsurance in exchange for the Preference Shares held which are reflected as treasury shares on the Consolidated Balance Sheet and are not treated as outstanding shares on December 31, 2023 and 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a result of the Exchange, the Preference Shares were delisted and no longer trade on the New York Stock Exchange, and there are no remaining issued and outstanding Preference Shares as at December 31, 2023 and 2022. All rights of the former holders related to ownership of the Preference Shares terminated upon completion of the Exchange.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2023, Maiden Reinsurance owns 29.9% of the Company's total outstanding common shares which is eliminated for accounting and financial reporting purposes on the Company's consolidated financial statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The voting power of Maiden Reinsurance, with respect to its common shares, is capped at 9.5% pursuant to the bye-laws of the Company. The ownership of the common shares by Maiden Reinsurance was made in compliance with Maiden Reinsurance's investment policy and approved by the Vermont Department of Financial Regulation ("Vermont DFR"). The Vermont DFR additionally specifically approved the ownership of the Company's common shares by Maiden Reinsurance related to the Exchange.</span></div>
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
28434000 usd
CY2023Q4 mhld Preferred Stock Shares Outstanding Held By Affiliates
PreferredStockSharesOutstandingHeldByAffiliates
13813116 shares
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> — The preparation of U.S. GAAP Consolidated Financial Statements requires management to make estimates and assumptions that affect the reported and disclosed amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates. The significant estimates include, but are not limited to, reserve for loss and loss adjustment expenses ("loss and LAE"), deferred gain on retroactive reinsurance; unearned premium for AmTrust, recoverability of reinsurance balances receivable, reinsurance recoverable on unpaid losses, funds withheld and deferred commission and other acquisition expenses; valuation of financial instruments and deferred tax assets; and the determination of an allowance for estimated credit losses on certain types of financial instruments which requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.</span></div>
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2022Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
0 usd
CY2023Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
0 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10
CY2022 mhld Preferred Stock Redemption Discount Impact On Common Stock Per Share
PreferredStockRedemptionDiscountImpactOnCommonStockPerShare
1.33
CY2023Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2023Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
1023000 usd
CY2023Q4 us-gaap Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
3240000 usd
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023 us-gaap Premiums Written Gross
PremiumsWrittenGross
23466000 usd
CY2023 us-gaap Premiums Written Net
PremiumsWrittenNet
23168000 usd
CY2023 us-gaap Premiums Earned Net
PremiumsEarnedNet
43969000 usd
CY2023 us-gaap Other Income
OtherIncome
39000 usd
CY2023 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
61228000 usd
CY2023 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
19462000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
12800000 usd
CY2023 mhld Underwriting Income Loss Net
UnderwritingIncomeLossNet
-49482000 usd
CY2023 mhld Investment Income And Gain Loss On Investments Net
InvestmentIncomeAndGainLossOnInvestmentsNet
45226000 usd
CY2023 mhld Interest And Amortization Expenses Net
InterestAndAmortizationExpensesNet
18226000 usd
CY2023 mhld Foreign Currency Transactionand Other Gain Lossbefore Tax
ForeignCurrencyTransactionandOtherGainLossbeforeTax
-5741000 usd
CY2023 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
17996000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
196000 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7846000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-38569000 usd
CY2022 us-gaap Premiums Written Gross
PremiumsWrittenGross
5479000 usd
CY2022 us-gaap Premiums Written Net
PremiumsWrittenNet
5082000 usd
CY2022 us-gaap Premiums Earned Net
PremiumsEarnedNet
37732000 usd
CY2022 us-gaap Other Income
OtherIncome
-4530000 usd
CY2022 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
57991000 usd
CY2022 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
18511000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
11634000 usd
CY2022 mhld Underwriting Income Loss Net
UnderwritingIncomeLossNet
-54934000 usd
CY2022 mhld Investment Income And Gain Loss On Investments Net
InvestmentIncomeAndGainLossOnInvestmentsNet
24930000 usd
CY2022 mhld Interest And Amortization Expenses Net
InterestAndAmortizationExpensesNet
19331000 usd
CY2022 mhld Foreign Currency Transactionand Other Gain Lossbefore Tax
ForeignCurrencyTransactionandOtherGainLossbeforeTax
8255000 usd
CY2022 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
19313000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-557000 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-205000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-60041000 usd
CY2023Q4 us-gaap Assets
Assets
1518934000 usd
CY2022Q4 us-gaap Assets
Assets
1846866000 usd
CY2023 us-gaap Premiums Written Gross
PremiumsWrittenGross
23466000 usd
CY2022 us-gaap Premiums Written Gross
PremiumsWrittenGross
5479000 usd
CY2023 us-gaap Premiums Written Net
PremiumsWrittenNet
23168000 usd
CY2022 us-gaap Premiums Written Net
PremiumsWrittenNet
5082000 usd
CY2023 us-gaap Premiums Earned Net
PremiumsEarnedNet
43969000 usd
CY2022 us-gaap Premiums Earned Net
PremiumsEarnedNet
37732000 usd
CY2023 us-gaap Premiums Written Net
PremiumsWrittenNet
23168000 usd
CY2022 us-gaap Premiums Written Net
PremiumsWrittenNet
5082000 usd
CY2023 us-gaap Premiums Earned Net
PremiumsEarnedNet
43969000 usd
CY2023 mhld Premiums Earned Net As Percent Of Total
PremiumsEarnedNetAsPercentOfTotal
1.000
CY2022 us-gaap Premiums Earned Net
PremiumsEarnedNet
37732000 usd
CY2022 mhld Premiums Earned Net As Percent Of Total
PremiumsEarnedNetAsPercentOfTotal
1.000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
258536000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
8000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7943000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
250601000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
330439000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
15913000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
314527000 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
1418000 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
1456000 usd
CY2023 us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
0 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
103579000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
102970000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
40821000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
38951000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
3627000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
3226000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
148027000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
145147000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
258536000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
250601000 usd
CY2023Q4 mhld Fixed Maturities Continuous Unrealized Loss Position Lessthan Twelve Months Fair Value
FixedMaturitiesContinuousUnrealizedLossPositionLessthanTwelveMonthsFairValue
8735000 usd
CY2023Q4 mhld Fixed Maturities Continuous Unrealized Loss Position Lessthan12 Months Accumulated Loss
FixedMaturitiesContinuousUnrealizedLossPositionLessthan12MonthsAccumulatedLoss
3000 usd
CY2023Q4 mhld Fixed Maturities Continuous Unrealized Loss Position Twelve Monthsor Longer Fair Value
FixedMaturitiesContinuousUnrealizedLossPositionTwelveMonthsorLongerFairValue
185141000 usd
CY2023Q4 mhld Fixed Maturities Continuous Unrealized Loss Position12 Monthsor Longer Accumulated Loss
FixedMaturitiesContinuousUnrealizedLossPosition12MonthsorLongerAccumulatedLoss
7940000 usd
CY2023Q4 mhld Fixed Maturities Continuous Unrealized Loss Position Fair Value
FixedMaturitiesContinuousUnrealizedLossPositionFairValue
193876000 usd
CY2023Q4 mhld Fixed Maturities Continuous Unrealized Loss Position Accumulated Loss
FixedMaturitiesContinuousUnrealizedLossPositionAccumulatedLoss
7943000 usd
CY2023Q4 mhld Fixed Securitiesin Unrealized Loss Positions Qualitative Disclosure Numberof Positions
FixedSecuritiesinUnrealizedLossPositionsQualitativeDisclosureNumberofPositions
59 security
CY2023Q4 mhld Investments Continuous Unrealized Loss Position Fair Value
InvestmentsContinuousUnrealizedLossPositionFairValue
193876000 usd
CY2023Q4 mhld Investments Continuous Unrealized Loss Position Accumulated Loss
InvestmentsContinuousUnrealizedLossPositionAccumulatedLoss
7943000 usd
CY2023Q4 mhld Fixed Securitiesin Unrealized Loss Positions Qualitative Disclosure Numberof Positions Greaterthanor Equalto One Year
FixedSecuritiesinUnrealizedLossPositionsQualitativeDisclosureNumberofPositionsGreaterthanorEqualtoOneYear
56 security
CY2023Q4 mhld Investments Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
InvestmentsContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
185141000 usd
CY2023Q4 mhld Investments Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses
InvestmentsContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses
7940000 usd
CY2022Q4 mhld Fixed Maturities Continuous Unrealized Loss Position Lessthan Twelve Months Fair Value
FixedMaturitiesContinuousUnrealizedLossPositionLessthanTwelveMonthsFairValue
208245000 usd
CY2022Q4 mhld Fixed Maturities Continuous Unrealized Loss Position Lessthan12 Months Accumulated Loss
FixedMaturitiesContinuousUnrealizedLossPositionLessthan12MonthsAccumulatedLoss
10425000 usd
CY2022Q4 mhld Fixed Maturities Continuous Unrealized Loss Position Twelve Monthsor Longer Fair Value
FixedMaturitiesContinuousUnrealizedLossPositionTwelveMonthsorLongerFairValue
103992000 usd
CY2022Q4 mhld Fixed Maturities Continuous Unrealized Loss Position12 Monthsor Longer Accumulated Loss
FixedMaturitiesContinuousUnrealizedLossPosition12MonthsorLongerAccumulatedLoss
5488000 usd
CY2022Q4 mhld Fixed Maturities Continuous Unrealized Loss Position Fair Value
FixedMaturitiesContinuousUnrealizedLossPositionFairValue
312237000 usd
CY2022Q4 mhld Fixed Maturities Continuous Unrealized Loss Position Accumulated Loss
FixedMaturitiesContinuousUnrealizedLossPositionAccumulatedLoss
15913000 usd
CY2022Q4 mhld Fixed Securitiesin Unrealized Loss Positions Qualitative Disclosure Numberof Positions
FixedSecuritiesinUnrealizedLossPositionsQualitativeDisclosureNumberofPositions
88 security
CY2022Q4 mhld Investments Continuous Unrealized Loss Position Fair Value
InvestmentsContinuousUnrealizedLossPositionFairValue
312237000 usd
CY2022Q4 mhld Investments Continuous Unrealized Loss Position Accumulated Loss
InvestmentsContinuousUnrealizedLossPositionAccumulatedLoss
15913000 usd
CY2022Q4 mhld Fixed Securitiesin Unrealized Loss Positions Qualitative Disclosure Numberof Positions Greaterthanor Equalto One Year
FixedSecuritiesinUnrealizedLossPositionsQualitativeDisclosureNumberofPositionsGreaterthanorEqualtoOneYear
26 security
CY2022Q4 mhld Investments Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
InvestmentsContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
103992000 usd
CY2022Q4 mhld Investments Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses
InvestmentsContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses
5488000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2023Q4 mhld Fixed Maturities Amortized Cost Basis
FixedMaturitiesAmortizedCostBasis
258536000 usd
CY2023Q4 mhld Fixed Maturities Fair Value
FixedMaturitiesFairValue
250601000 usd
CY2023Q4 mhld Fixed Maturities Percentof Total Fair Value
FixedMaturitiesPercentofTotalFairValue
1.000
CY2022Q4 mhld Fixed Maturities Amortized Cost Basis
FixedMaturitiesAmortizedCostBasis
330439000 usd
CY2022Q4 mhld Fixed Maturities Fair Value
FixedMaturitiesFairValue
314527000 usd
CY2022Q4 mhld Fixed Maturities Percentof Total Fair Value
FixedMaturitiesPercentofTotalFairValue
1.000
CY2023Q4 us-gaap Other Investment Not Readily Marketable Fair Value
OtherInvestmentNotReadilyMarketableFairValue
113806000 usd
CY2023Q4 mhld Other Investments Percent Of Total Fair Value
OtherInvestmentsPercentOfTotalFairValue
0.622
CY2022Q4 us-gaap Other Investment Not Readily Marketable Fair Value
OtherInvestmentNotReadilyMarketableFairValue
92666000 usd
CY2022Q4 mhld Other Investments Percent Of Total Fair Value
OtherInvestmentsPercentOfTotalFairValue
0.623
CY2023Q4 us-gaap Other Investments
OtherInvestments
182811000 usd
CY2023Q4 mhld Other Investments Percent Of Total
OtherInvestmentsPercentOfTotal
1.000
CY2022Q4 us-gaap Other Investments
OtherInvestments
148753000 usd
CY2022Q4 mhld Other Investments Percent Of Total
OtherInvestmentsPercentOfTotal
1.000
CY2023Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
1023000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
43439000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
45299000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
40509000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
43621000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
80929000 usd
CY2023Q4 mhld Equity Method Investments Percent Of Total
EquityMethodInvestmentsPercentOfTotal
1.000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
80159000 usd
CY2022Q4 mhld Equity Method Investments Percent Of Total
EquityMethodInvestmentsPercentOfTotal
1.000
CY2023 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
37942000 usd
CY2022 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
30470000 usd
CY2023 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
564000 usd
CY2022 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
400000 usd
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
37378000 usd
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
30070000 usd
CY2023 mhld Equity Securities Fvni Realized And Unrealized Gain
EquitySecuritiesFVNIRealizedAndUnrealizedGain
3923000 usd
CY2023 mhld Equity Securities Fvni Realized And Unrealized Loss
EquitySecuritiesFVNIRealizedAndUnrealizedLoss
431000 usd
CY2023 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
3492000 usd
CY2023 mhld Realized And Unrealized Gain On Investments
RealizedAndUnrealizedGainOnInvestments
14506000 usd
CY2023 mhld Realized And Unrealized Loss On Investments
RealizedAndUnrealizedLossOnInvestments
6658000 usd
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
7848000 usd
CY2022 mhld Equity Securities Fvni Realized And Unrealized Gain
EquitySecuritiesFVNIRealizedAndUnrealizedGain
3770000 usd
CY2022 mhld Equity Securities Fvni Realized And Unrealized Loss
EquitySecuritiesFVNIRealizedAndUnrealizedLoss
1434000 usd
CY2022 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
2336000 usd
CY2022 mhld Realized And Unrealized Gain On Investments
RealizedAndUnrealizedGainOnInvestments
7142000 usd
CY2022 mhld Realized And Unrealized Loss On Investments
RealizedAndUnrealizedLossOnInvestments
12282000 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
-5140000 usd
CY2023 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
3492000 usd
CY2022 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
2336000 usd
CY2023 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
4957000 usd
CY2022 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
111000 usd
CY2023 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1465000 usd
CY2022 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
2225000 usd
CY2023 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
98993000 usd
CY2022 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
213944000 usd
CY2023Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
151000 usd
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
244000 usd
CY2023Q4 mhld Investments Gross Unrealized Gain Loss Net Of Deferred Income Tax Expense
InvestmentsGrossUnrealizedGainLossNetOfDeferredIncomeTaxExpense
-7784000 usd
CY2022Q4 mhld Investments Gross Unrealized Gain Loss Net Of Deferred Income Tax Expense
InvestmentsGrossUnrealizedGainLossNetOfDeferredIncomeTaxExpense
-15668000 usd
CY2023 mhld Other Comprehensive Income Loss Investments Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossInvestmentsAdjustmentNetOfTaxPortionAttributableToParent
7884000 usd
CY2022 mhld Other Comprehensive Income Loss Investments Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossInvestmentsAdjustmentNetOfTaxPortionAttributableToParent
-12975000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7266000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
15638000 usd
CY2023Q4 us-gaap Restricted Investments
RestrictedInvestments
212608000 usd
CY2022Q4 us-gaap Restricted Investments
RestrictedInvestments
281192000 usd
CY2023Q4 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
219874000 usd
CY2022Q4 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
296830000 usd
CY2023 mhld Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag
Underwriting-related derivative liability
CY2022 mhld Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag
Underwriting-related derivative liability
CY2022Q4 mhld Assets Fair Value Disclosure Number Of Securities Priced For Fair Value
AssetsFairValueDisclosureNumberOfSecuritiesPricedForFairValue
1 security
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
18806000 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
7094000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
7669000 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
2000000 usd
CY2023 mhld Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Other Comprehensive Income Extensible List Not Disclosed Flag
FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag
Net realized and unrealized gains recognized in the statement of income
CY2022 mhld Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Other Comprehensive Income Extensible List Not Disclosed Flag
FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag
Net realized and unrealized gains recognized in the statement of income
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
3723000 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
3770000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
7476000 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
9942000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
30147000 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
52483000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
18806000 usd
CY2023Q2 mhld Common Stock Authorized Share Capital At Par Value
CommonStockAuthorizedShareCapitalAtParValue
1500000 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 mhld Common Stock Authorized Share Capital At Par Value
CommonStockAuthorizedShareCapitalAtParValue
2000000 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 mhld Share Capital Shares Authorized
ShareCapitalSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
149732355 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100472120 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
49260235 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
50267645 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 mhld Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1 period
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101532151 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86467242 shares
CY2023 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
0 shares
CY2022 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
55800000 shares
CY2023 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
508275 shares
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1107973 shares
CY2023 mhld Treasury Stock Shares Acquired Including Shares Paid For Tax Withholding For Share Based Compensation
TreasuryStockSharesAcquiredIncludingSharesPaidForTaxWithholdingForShareBasedCompensation
128731 shares
CY2022 mhld Treasury Stock Shares Acquired Including Shares Paid For Tax Withholding For Share Based Compensation
TreasuryStockSharesAcquiredIncludingSharesPaidForTaxWithholdingForShareBasedCompensation
403716 shares
CY2023 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1439575 shares
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2023 mhld Common Shares Held By Subsidiary In Exchange For Preference Shares
CommonSharesHeldBySubsidiaryInExchangeForPreferenceShares
0 shares
CY2022 mhld Common Shares Held By Subsidiary In Exchange For Preference Shares
CommonSharesHeldBySubsidiaryInExchangeForPreferenceShares
41439348 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100472120 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101532151 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
49260235 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
47691929 shares
CY2023 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
9765000 usd
CY2022 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-22212000 usd
CY2022 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
6807000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-29019000 usd
CY2023 us-gaap Direct Premiums Written
DirectPremiumsWritten
27265000 usd
CY2022 us-gaap Direct Premiums Written
DirectPremiumsWritten
24553000 usd
CY2023 us-gaap Assumed Premiums Written
AssumedPremiumsWritten
-3799000 usd
CY2022 us-gaap Assumed Premiums Written
AssumedPremiumsWritten
-19074000 usd
CY2023 us-gaap Ceded Premiums Written
CededPremiumsWritten
298000 usd
CY2022 us-gaap Ceded Premiums Written
CededPremiumsWritten
397000 usd
CY2023 us-gaap Premiums Written Net
PremiumsWrittenNet
23168000 usd
CY2022 us-gaap Premiums Written Net
PremiumsWrittenNet
5082000 usd
CY2023 us-gaap Direct Premiums Earned
DirectPremiumsEarned
27049000 usd
CY2022 us-gaap Direct Premiums Earned
DirectPremiumsEarned
24534000 usd
CY2023 us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
17202000 usd
CY2022 us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
13599000 usd
CY2023 us-gaap Ceded Premiums Earned
CededPremiumsEarned
282000 usd
CY2022 us-gaap Ceded Premiums Earned
CededPremiumsEarned
401000 usd
CY2023 us-gaap Premiums Earned Net
PremiumsEarnedNet
43969000 usd
CY2022 us-gaap Premiums Earned Net
PremiumsEarnedNet
37732000 usd
CY2023 us-gaap Policyholder Benefits And Claims Incurred Gross
PolicyholderBenefitsAndClaimsIncurredGross
59562000 usd
CY2022 us-gaap Policyholder Benefits And Claims Incurred Gross
PolicyholderBenefitsAndClaimsIncurredGross
53508000 usd
CY2023 us-gaap Reinsurance Costs And Recoveries Net
ReinsuranceCostsAndRecoveriesNet
-1666000 usd
CY2022 us-gaap Reinsurance Costs And Recoveries Net
ReinsuranceCostsAndRecoveriesNet
-4483000 usd
CY2023 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
61228000 usd
CY2022 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
57991000 usd
CY2023Q4 us-gaap Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
564331000 usd
CY2022Q4 us-gaap Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
556116000 usd
CY2023Q4 us-gaap Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
3240000 usd
CY2022Q4 us-gaap Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
4277000 usd
CY2023 us-gaap Reinsurance Recoverable Credit Loss Expense Reversal
ReinsuranceRecoverableCreditLossExpenseReversal
-1037000 usd
CY2023Q4 us-gaap Reinsurance Recoverables Allowance
ReinsuranceRecoverablesAllowance
3240000 usd
CY2019Q3 mhld Reinsurance Recoverable For Paid And Unpaid Claims And Claims Adjustments Ceded Cumulative Losses
ReinsuranceRecoverableForPaidAndUnpaidClaimsAndClaimsAdjustmentsCededCumulativeLosses
445000000 usd
CY2018Q4 mhld Reinsurance Recoverable For Paid And Unpaid Claims And Claims Adjustments Adverse Development Cover
ReinsuranceRecoverableForPaidAndUnpaidClaimsAndClaimsAdjustmentsAdverseDevelopmentCover
155000000 usd
CY2019Q3 mhld Reinsurance Recoverable For Paid And Unpaid Claims And Claims Adjustments Ceded Cumulative Losses
ReinsuranceRecoverableForPaidAndUnpaidClaimsAndClaimsAdjustmentsCededCumulativeLosses
445000000 usd
CY2023Q4 mhld Reinsurance Collateral By Third Party
ReinsuranceCollateralByThirdParty
490070000 usd
CY2023 us-gaap Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
The reserve for loss and LAE comprises: <div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"></td><td style="width:72.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.530%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for reported loss and LAE</span></div></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543,818 </span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702,691 </span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for losses incurred but not reported ("IBNR")</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323,615 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428,717 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccffcc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for loss and LAE</span></div></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td style="background-color:#ccffcc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccffcc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867,433 </span></td><td style="background-color:#ccffcc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td style="background-color:#ccffcc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccffcc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,131,408 </span></td><td style="background-color:#ccffcc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following table represents a reconciliation of the beginning and ending gross and net loss and LAE reserves: </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:72.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross loss and LAE reserves, January 1</span></div></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,131,408 </span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489,373 </span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: reinsurance recoverable on unpaid losses, January 1</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556,116 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,845 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccffcc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss and LAE reserves, January 1</span></div></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,292 </span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926,528 </span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net incurred losses related to:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccffcc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></div></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,040 </span></td><td style="background-color:#ccffcc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,355 </span></td><td style="background-color:#ccffcc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,188 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,228 </span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,991 </span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net paid losses related to:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccffcc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></div></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(837)</span></td><td style="background-color:#ccffcc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(701)</span></td><td style="background-color:#ccffcc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321,206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398,499)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(322,043)</span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(399,200)</span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred gain on retroactive reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccffcc;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GLS run-off business acquired or assumed</span></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ccffcc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,905 </span></td><td style="background-color:#ccffcc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opening allowance for expected credit loss on reinsurance recoverable on unpaid losses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccffcc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign exchange rate movements</span></div></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,880 </span></td><td style="background-color:#ccffcc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,519)</span></td><td style="background-color:#ccffcc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss and LAE reserves, December 31</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303,102 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,292 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccffcc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverable on unpaid losses, December 31</span></div></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564,331 </span></td><td style="background-color:#ccffcc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="2" style="background-color:#ccffcc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556,116 </span></td><td style="background-color:#ccffcc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross loss and LAE reserves, December 31</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867,433 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,131,408 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div>The following table summarizes the adverse prior period development experienced in each of our reportable segments for the years ended December 31, 2023 and 2022:<div style="margin-bottom:1pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diversified Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">AmTrust Reinsurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,440)</span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,748)</span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccffcc;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,188)</span></td><td style="background-color:#ccffcc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div>
CY2023Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Reported Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount
543818000 usd
CY2022Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Reported Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount
702691000 usd
CY2023Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
323615000 usd
CY2022Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
428717000 usd
CY2023Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
867433000 usd
CY2022Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
1131408000 usd
CY2022Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
1131408000 usd
CY2021Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
1489373000 usd
CY2022Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
556116000 usd
CY2021Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
562845000 usd
CY2022Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
575292000 usd
CY2021Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
926528000 usd
CY2023 us-gaap Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
23040000 usd
CY2022 us-gaap Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
25355000 usd
CY2023 us-gaap Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
38188000 usd
CY2022 us-gaap Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
32636000 usd
CY2023 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
61228000 usd
CY2022 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
57991000 usd
CY2023 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
837000 usd
CY2022 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
701000 usd
CY2023 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
321206000 usd
CY2022 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
398499000 usd
CY2023 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
322043000 usd
CY2022 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
399200000 usd
CY2023 mhld Liability For Unpaid Claims And Claims Adjustment Expense Retroactive Reinsurance Adjustment
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRetroactiveReinsuranceAdjustment
25532000 usd
CY2022 mhld Liability For Unpaid Claims And Claims Adjustment Expense Retroactive Reinsurance Adjustment
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRetroactiveReinsuranceAdjustment
-3587000 usd
CY2023 mhld Liability For Unpaid Claims And Claims Adjustment Expense Assumed Business
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAssumedBusiness
0 usd
CY2022 mhld Liability For Unpaid Claims And Claims Adjustment Expense Assumed Business
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAssumedBusiness
10905000 usd
CY2023Q4 mhld Liability For Unpaid Claims And Claims Adjustment Expense Allowance For Expected Credit Losses On Recoverables
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAllowanceForExpectedCreditLossesOnRecoverables
4277000 usd
CY2022Q4 mhld Liability For Unpaid Claims And Claims Adjustment Expense Allowance For Expected Credit Losses On Recoverables
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAllowanceForExpectedCreditLossesOnRecoverables
0 usd
CY2023 mhld Liability For Unpaid Claims And Claims Adjustment Expense Foreign Currency Transaction And Translation Adjustment
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTransactionAndTranslationAdjustment
-9880000 usd
CY2022 mhld Liability For Unpaid Claims And Claims Adjustment Expense Foreign Currency Transaction And Translation Adjustment
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseForeignCurrencyTransactionAndTranslationAdjustment
24519000 usd
CY2023Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
303102000 usd
CY2022Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
575292000 usd
CY2023Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
564331000 usd
CY2022Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
556116000 usd
CY2023Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
867433000 usd
CY2022Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
1131408000 usd
CY2023 mhld Liabilityfor Unpaid Claimsand Claims Adjustment Expense Period Increase Decrease Netof Commission Changes
LiabilityforUnpaidClaimsandClaimsAdjustmentExpensePeriodIncreaseDecreaseNetofCommissionChanges
38188000 usd
CY2022 mhld Liabilityfor Unpaid Claimsand Claims Adjustment Expense Period Increase Decrease Netof Commission Changes
LiabilityforUnpaidClaimsandClaimsAdjustmentExpensePeriodIncreaseDecreaseNetofCommissionChanges
32636000 usd
CY2023 us-gaap Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
38188000 usd
CY2023 mhld Percentageof Prior Year Net Lossand Loss Adjustment Expense Reserves
PercentageofPriorYearNetLossandLossAdjustmentExpenseReserves
0.066
CY2022 us-gaap Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
32636000 usd
CY2022 mhld Percentageof Prior Year Net Lossand Loss Adjustment Expense Reserves
PercentageofPriorYearNetLossandLossAdjustmentExpenseReserves
0.035
CY2023 mhld Liabilityfor Unpaid Claimsand Claims Adjustment Expense Period Increase Decrease Netof Commission Changes
LiabilityforUnpaidClaimsandClaimsAdjustmentExpensePeriodIncreaseDecreaseNetofCommissionChanges
38188000 usd
CY2023 mhld Liability For Unpaid Claims And Claims Adjustment Expense Retroactive Reinsurance Adjustment
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRetroactiveReinsuranceAdjustment
25532000 usd
CY2022 mhld Liability For Unpaid Claims And Claims Adjustment Expense Retroactive Reinsurance Adjustment
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseRetroactiveReinsuranceAdjustment
-3587000 usd
CY2023 mhld Short Duration Insurance Contracts Number Of Major Contracts
ShortDurationInsuranceContractsNumberOfMajorContracts
2 contract
CY2023Q4 mhld Short Duration Insurance Contract Policy Limit
ShortDurationInsuranceContractPolicyLimit
1000000 usd
CY2023Q4 mhld Short Duration Insurance Contract Policy Limit
ShortDurationInsuranceContractPolicyLimit
1000000 usd
CY2023Q4 us-gaap Shortduration Insurance Contracts Liability For Unpaid Claims And Allocated Claim Adjustment Expense Net
ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet
303102000 usd
CY2023Q4 us-gaap Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
564331000 usd
CY2023Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
867433000 usd
CY2023 us-gaap Receivable With Imputed Interest Effective Yield Interest Rate
ReceivableWithImputedInterestEffectiveYieldInterestRate
0.070
CY2022 us-gaap Receivable With Imputed Interest Effective Yield Interest Rate
ReceivableWithImputedInterestEffectiveYieldInterestRate
0.037
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
40479000 usd
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
40319000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
228000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
228000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
300000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
300000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y2M12D
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
478000 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
375000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
201000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
42000 usd
CY2023Q4 mhld Lessee Operating Lease Liability Fair Value Discount
LesseeOperatingLeaseLiabilityFairValueDiscount
15000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
228000 usd
CY2023Q4 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments
65631000 usd
CY2023Q4 mhld Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Commitments Percentage Of Total
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommitmentsPercentageOfTotal
0.651
CY2022Q4 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments
69607000 usd
CY2022Q4 mhld Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Commitments Percentage Of Total
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommitmentsPercentageOfTotal
0.616
CY2023Q4 us-gaap Other Commitment
OtherCommitment
62508000 usd
CY2022Q4 us-gaap Other Commitment
OtherCommitment
42141000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-38569000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-60041000 usd
CY2023 mhld Preferred Stock Redemption Exchange
PreferredStockRedemptionExchange
0 usd
CY2022 mhld Preferred Stock Redemption Exchange
PreferredStockRedemptionExchange
87240000 usd
CY2023 us-gaap Preferred Stock Redemption Discount
PreferredStockRedemptionDiscount
0 usd
CY2022 us-gaap Preferred Stock Redemption Discount
PreferredStockRedemptionDiscount
28233000 usd
CY2023 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2022 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
314000 usd
CY2023 us-gaap Undistributed Earnings Loss Available To Common Shareholders Diluted
UndistributedEarningsLossAvailableToCommonShareholdersDiluted
-38569000 usd
CY2023 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
-38569000 usd
CY2022 us-gaap Undistributed Earnings Loss Available To Common Shareholders Diluted
UndistributedEarningsLossAvailableToCommonShareholdersDiluted
55118000 usd
CY2022 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
55118000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101382606 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87112711 shares
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1263 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101382606 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87113974 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1263 shares
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-32456000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-20509000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-5917000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-40089000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38373000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-60598000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-146000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-478000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-146000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-478000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
342000 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-79000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
342000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-79000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
196000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-557000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38373000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-60598000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
196000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-557000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-38569000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-60041000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0
CY2023 mhld Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential United States
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferentialUnitedStates
-0.020
CY2022 mhld Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential United States
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferentialUnitedStates
0.365
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.020
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.365
CY2023 mhld Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential Other Than United States
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferentialOtherThanUnitedStates
-0.005
CY2022 mhld Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential Other Than United States
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferentialOtherThanUnitedStates
0.009
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.005
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.009
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
70858000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
58939000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve
1929000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve
2813000 usd
CY2023Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
2909000 usd
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
3036000 usd
CY2023Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
17223000 usd
CY2022Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
23276000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
14542000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
22964000 usd
CY2023Q4 mhld Deferred Tax Assets Deferred Gain On Reinsurance
DeferredTaxAssetsDeferredGainOnReinsurance
14892000 usd
CY2022Q4 mhld Deferred Tax Assets Deferred Gain On Reinsurance
DeferredTaxAssetsDeferredGainOnReinsurance
11032000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2373000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1175000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
124726000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
123235000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
119742000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
116237000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4984000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
6998000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost
DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost
4195000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost
DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost
5767000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
56000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4195000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5823000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
789000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1175000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
789000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1175000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3505000 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
26160000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
186203000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
179549000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
151217000 usd
CY2023Q4 mhld Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration Percentage
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpirationPercentage
44.8
CY2023Q4 mhld Capital Loss Carryforwards
CapitalLossCarryforwards
13853000 usd
CY2022Q4 mhld Capital Loss Carryforwards
CapitalLossCarryforwards
14458000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
215000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.91
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M10D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13000 usd
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7500 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.31
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
57250 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
7.20
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
6250 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.20
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
144000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.72
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y4M24D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
22500 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.48
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
121500 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.58
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y11M19D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
121500 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.58
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y11M19D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q4 mhld Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
2.22
CY2022Q4 mhld Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
2.29
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7500 shares
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1725000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2740000 usd
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
795000 usd
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
707000 usd

Files In Submission

Name View Source Status
0001412100-24-000014-index-headers.html Edgar Link pending
0001412100-24-000014-index.html Edgar Link pending
0001412100-24-000014.txt Edgar Link pending
0001412100-24-000014-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mhld-20231231.htm Edgar Link pending
mhld-20231231.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mhld-20231231_cal.xml Edgar Link unprocessable
mhld-20231231_def.xml Edgar Link unprocessable
mhld-20231231_htm.xml Edgar Link completed
q42023ex211subsidiariesofr.htm Edgar Link pending
q42023ex231consentofey-only.htm Edgar Link pending
q42023exhibit22-10konly.htm Edgar Link pending
q42023exhibit311.htm Edgar Link pending
q42023exhibit312.htm Edgar Link pending
q42023exhibit321.htm Edgar Link pending
q42023exhibit322.htm Edgar Link pending
q42023exhibit971.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mhld-20231231_lab.xml Edgar Link unprocessable
mhld-20231231_pre.xml Edgar Link unprocessable